Clozapine rechallenge after clozapine-induced myocarditis: A case report to validate a previously published protocol
Introduction Clozapine is an effective antipsychotic indicated for treatment-resistant schizophrenia (TRS). Its use is limited by its extensive adverse effect profile featuring rare but serious consequences like clozapine-induced myocarditis (CIM). In the event of CIM, clozapine is discontinued; how...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Association of Psychiatric Pharmacists
2025-10-01
|
| Saila: | Mental Health Clinician |
| Gaiak: | |
| Sarrera elektronikoa: | https://theijpt.org/doi/pdf/10.9740/mhc.2025.10.237 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|